Methylnaltrexone

Records for this ingredient, by country (identity only).

ATC A06AH01 · 6 markets · 13 records

Methylnaltrexone 6 markets · 13 records Forms
Filters
MarketUS 3CA 3AU 3ES 2GB 1

US 3 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

CA 3 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 20 mg per mL / per unit basis not statedliquidRelistor

AU 3 records · 1 shown of 1 Source PBS Schedule API v3 (Department of、TGA CMI repository (consumer medic · Data as of 2026-10-01、live · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Relistor ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

ES 2 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

  • 12 mg per mL / per unit basis not statedinjectionRelistor

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 12 mg/0.6 mLinjectionRelistor 12mg/0.6ml solution for injection vials also in US·AU

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.